Are you an early stage digital solution targeting point-of-care outcomes who would benefit from collaborating with clinical experts and a global biopharma company? If your answer is yes, we would be interested in learning more about your solution(s).

Through its Digital Patient Workflow Solution (DPWS) collaboration, UCSF’s Center for Digital Health Innovation (CDHI) and WeHealth By Servier are looking for early stage companies developing digital therapeutics and clinical decision support solutions in the following five therapeutic areas:

— Cardiovascular diseases
Diabetes
— Cancer
Neuropsychiatric diseases
Immune-inflammatory diseases

Between April and June, CDHI and WeHealth will be accepting applications for the ultimate goal of establishing an agreement for funding and mentorship with one or two early stage companies. Our team will then conduct due diligence on companies who apply below, and qualifying candidates will be invited to present in September. The final selection of companies will occur in October.

Criteria for Applying

— Seed funding to Series B companies only, preferably with no pre-existing biopharma funding

— Applying company to have a digital solution (either clinical decision support or digital therapeutic) that impacts the patient journey in the disease areas of oncology, cardiovascular, diabetes, neuropsychiatric or immune-inflammatory diseases

— The digital solution has the potential for global impact and dissemination within a three to five year timeframe

Do you meet the above criteria? If so, apply now!

* indicates required field
  • Tell us about your solution!

  • (ex. Link to dropbox, googledocs, or box file)
  • Tell us about your company!

  • Tell us how to get in touch with you!